NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 6.25
+0.09 (1.46%)
At close: Dec 19, 2025
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 489.79 million as of December 19, 2025. Its market cap has increased by 156.11% in one year.
Market Cap
489.79M
Enterprise Value
478.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.25
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 489.79M, an increase of 878.18%. That is a compound annual growth rate of 40.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 489.79M | 121.86% |
| Dec 31, 2024 | 220.77M | 37.18% |
| Dec 29, 2023 | 160.94M | 71.42% |
| Dec 30, 2022 | 93.89M | -24.19% |
| Dec 31, 2021 | 123.84M | 58.14% |
| Dec 31, 2020 | 78.31M | 36.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.41B |
| Green Thumb Industries | 2.55B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.11B |
| Sienna Senior Living | 2.00B |
| Trulieve Cannabis | 2.00B |
| Cronos Group | 1.56B |
| WELL Health Technologies | 985.46M |